"It would eliminate the age limits," . Morgan Bailey, a partner at Mayer Brown and former senior DHS official told Newsweek.

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

Before adopting AI tools, businesses should follow a structured evaluation process that goes beyond feature comparisons and vendor demonstrations. AI tools can expose businesses to regulatory ...